Holocene Advisors, LP Revance Therapeutics, Inc. Transaction History

Holocene Advisors, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$24.7 - $37.61 $2.32 Million - $3.53 Million	-93,852 Reduced 10.02%	842,563 $21.3 Million
Q1 2023 May 15, 2023	SELL	$18.36 - $35.27 $6.8 Million - $13.1 Million	-370,245 Reduced 28.34%	936,415 $30.2 Million
Q4 2022 Feb 14, 2023	BUY	$18.32 - $30.66 $4.41 Million - $7.38 Million	240,698 Added 22.58%	1,306,660 $24.1 Million
Q3 2022 Nov 14, 2022	BUY	$14.33 - $28.47 $15.3 Million - $30.3 Million	1,065,962 New	1,065,962 $28.8 Million

234

82.8M

680K

896K

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

Stay updated on Holocene Advisors, LP with notifications on news.